InflammaCore Vanilla Chai - 14 SVG

InflammaCore Vanilla Chai - 14 SVG by Ortho Molecular Products

InflammaCore Vanilla Chai - 14svg by Ortho Molecular Products is designed as an anti-inflammatory supplement, though it may also have additional health benefits.* The formulation used consists of tens of different crucial nutrients, making it an excellent choice for those who cannot provide all the essential vitamins and minerals in their diet.*

Who May Consider InflammaCore Vanilla Chai - 14svg?

InflammaCore Vanilla Chai - 14svg may support your health if you:

• suffer from chronic inflammatory conditions*
• experience gastrointestinal discomfort*
• are an athlete wanting to support regeneration*
• consume insufficient amounts of nutrients in your diet*

InflammaCore Vanilla Chai - 14svg by Ortho Molecular Products—Effects

InflammaCore Vanilla Chai - 14svg may support:

• anti-inflammation*
• gastrointestinal health*
• immune function*
• regeneration*
• general nutrition*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about this product.

Recommendation:
Ortho Molecular Products suggests mixing 2 scoops (50.5 grams) of InflammaCORE immune system booster powder with 8-10 ounces of the beverage of your choice to the desired thickness, once daily or as recommended by your health care professional.

Serving Size: 2 Scoops (50.5 grams)
Servings Per Container: 14

Amount Per Serving:
Calories 200
Total Fat 6 g
Saturated Fat 3 g
Total Carbohydrate 12 g
Dietary Fiber 4 g
Total Sugars 8 g (includes 8 g Added Sugars)
Protein 19 g 
Vitamin D3 (as Cholecalcifeol) 2,000 IU  (50 mcg)
Calcium 30 mg
Iron 0.6 mg
Sodium 50 mg
Potassium 55 mg
Proprietary Blend 28.5 g
Rice Protein (ORYZAPRO)
Organic Flaxseed Flour
L-Glutamine USP 2.5 g
Medium Chain Triglycerides 1.5 g
Alpha Linolenic Acid (from Organic Flaxseed Flour) 1.3 g
Arabinogalactan Heartwood (from Larch Tree) 1 g
L-Lysine Hydrochloride USP 750 mg 
Glycine USP 500 mg
L-Proline USP 500 mg 
Quercetin Dihydrate 250 mg
Skullcap Root Extract (Standardized to contain 30% Flavones as S. baicalensis) 250 mg
Turmeric Root Extract (Standardized to contain 95% Curcuminoids) 250 mg
Propolis Extract 200 mg
Green Tea Leaf Extract (Standardized to contain 45% EGCg (Epigallocatechin gallate)) 100 mg
Ginger Root Extract (Standardized to contain 5% Gingerols) 100 mg
Rosemary Leaf Extract 100 mg

Other Ingredients: Whole Grain Brown Rice Sweetener (Organic)(Oryza ), Natural Flavors, Silicon Dioxide, Ascorbyl Palmitate, Guar Gum, Gum Acacia, Xanthan Gum and Rebaudioside A (Organic).

Caution: Do not consume this product if you are pregnant or nursing. Consult your physician for further information. 

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Click here to view Product Info Sheet

References:

1. Kumar, S., Ahuja, V., Sankar, M. J., Kumar, A., & Moss, A. C. (2012). Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews, 2012(10), CD008424. https://doi.org/10.1002/14651858.CD008424.pub2
2. Baliga, M. S., Joseph, N., Venkataranganna, M. V., Saxena, A., Ponemone, V., & Fayad, R. (2012). Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: Preclinical and clinical observations. Food & Function, 3(11), 1109-1117.
3. Bengmark, S., Mesa, M. D., & Gil, A. (2009). Plant-derived health: The effects of turmeric and curcuminoids. Nutrición Hospitalaria, 24(3), 273-281.
4. Kapakos, G., Youreva, V., & Srivastava, A. K. (2012). Cardiovascular protection by curcumin: Molecular aspects. Indian Journal of Biochemistry & Biophysics, 49(5), 306-315.
5. Lopresti, A. L., Hood, S. D., & Drummond, P. D. (2012). Multiple antidepressant potential modes of action of curcumin: A review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. Journal of Psychopharmacology, 26(12), 1512-1524.
6. Li, M., Liu, J. T., Pang, X. M., Han, C. J., & Mao, J. J. (2012). Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages. Pharmacological Reports, 64(4), 912-918.
7. Melgarejo, E., Medina, M. A., Sánchez-Jiménez, F., & Urdiales, J. L. (2010). Targeting of histamine producing cells by EGCG: A green dart against inflammation? Journal of Physiology and Biochemistry, 66(3), 265-270.
8. Singh, R., Akhtar, N., & Haqqi, T. M. (2010). Green tea polyphenol epigallocatechin-3-gallate: Inflammation and arthritis. Life Sciences, 86(25-26), 907-918.
9. Kelly, G. S. (1999). Larch arabinogalactan: Clinical relevance of a novel immune-enhancing polysaccharide. Alternative Medicine Review, 4(2), 96-103.
10. Riede, L., Grube, B., & Gruenwald, J. (2013). Larch arabinogalactan effects on reducing incidence of upper respiratory infections. Current Medical Research and Opinion, 29(3), 251-258.
11. Li-Weber, M. (2009). New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treatment Reviews, 35(1), 57-68.
12. Mabalirajan, U., Ahmad, T., Rehman, R., Leishangthem, G.D., Dinda A.K., Agrawal A., Ghosh B., & Sharma S.K.(2013). Baicalein reduces airway injury in allergen and IL-13 induced airway inflammation.PLoS One, 8(4), e62916.
13. Bito T., Roy S., Sen C.K., et al.(2002). Flavonoids differentially regulate IFN gamma-induced ICAM-1 expression in human keratinocytes: Molecular mechanisms of action.FEBS Letters, 520(1-3),145-152.
14. Amasheh M., Schlichter S., Amasheh S., Mankertz J., Zeitz M., Fromm M., & Schulzke J.D.(2008). Quercetin enhances epithelial barrier function and increases claudin-4 expression in Caco-2 cells.Journal of Nutrition, 138(6),1067-1073.
15. Penissi A.B., Rudolph M.I., & Piezzi R.S.(2003). Role of mast cells in gastrointestinal mucosal defense.Biocell, 27(2),163-172.
16. Wang W.W., Qiao S.Y., & Li D.F.(2009). Amino acids and gut function.Amino Acids, 37(1),105-110.
17. Bonet A.& Grau T.(2007). Glutamine: An almost essential amino acid in the critically ill patient.Medicina Intensiva, 31(7),402-406.
18. Dai Z.L., Wu G.& Zhu W.Y.(2011). Amino acid metabolism in intestinal bacteria: Links between gut ecology and host health.Frontiers in Bioscience, 16,1768-1786.
19. Hossein-nezhad A., Spira A.& Holick M.F.(2013). Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: A randomized double-blind clinical trial.PLoS One, 8(3),e58725.
20. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F.& Giovannucci E.(2006). Epidemic influenza and vitamin D.Epidemiology and Infection, 134(6),1129-1140.
21. Pappa H.M., Grand R.J.& Gordon C.M.(2006). Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease.Inflammatory Bowel Diseases, 12(12),1162-1174.